Portfolio News – Page 154 – Boston Harbor Angels

10JunJune 10, 2017

Myomo, Inc. Completes Historic Initial Public Offering

Myomo, Inc., a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares of its common stock at a price to the public of $7.50 per share. Read more >>

Portfolio NewsMyomo

09JunJune 9, 2017

Platelet Biogenesis Raises a $10 Million Series A Financing Led by Qiming U.S. Healthcare Fund

Platelet BioGenesis, a biotech startup developing a process to produce life-saving human platelets from stem cells for therapeutic applications, announced it has successfully raised $10 million in Series A financing. Read more >>

Portfolio NewsPlatelet BioGenesis

09JunJune 9, 2017

Siamab Therapeutics to Present at the 2017 BIO International Convention

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies targeting tumor-associated carbohydrate antigens (TACAs), today announced that Jeff Behrens, president and chief executive officer, will present at the 2017 BIO International Convention. Read more >>

Portfolio NewsSiamab Therapeutics

08JunJune 8, 2017

Ultracell Insulation $850000 Fundraising. Jonathan Strimling Filed Jun 7 Form D

Ultracell Insulation, Llc, Limited Liability Company just submitted form D about $850,000 debt financing. This is a new filing. Ultracell Insulation, Llc is expected to sell $850,000 in this round of financing. Read more >>

Portfolio NewsCleanFiber

08JunJune 8, 2017

Smart glasses give legally blind man second chance to see his wife at their wedding

A pair of eSight 3 smart glasses have given Airey something close to 20/20 vision. Recently Airey and his family were able to recreate their wedding while he wore the device. The wedding was at the same church from 15 years ago and the ceremony included the same cake and many of the same guests. Read more >>

Portfolio NewseSight

07JunJune 7, 2017

Chronix presents head/neck cancer data at ASCO

Chronix Biomedical presents positive data on prognostic test in head/neck cancer study at ASCO. Read more >>

Portfolio NewsChronix Biomedical

04JunJune 4, 2017

Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?

We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Read more >>

Portfolio NewsMyomo

04JunJune 4, 2017

Will Wasabi’s cheap, fast commodity storage disrupt Amazon S3?

After starting six companies with fellow tech veteran Jeff Flowers since 1980, Wasabi Technologies Inc. co-founder David Friend has clearly learned to name names when it comes to competition. Read more >>

Portfolio NewsWasabi

03JunJune 3, 2017

Meet Blurr — the Gen Z Answer to Instagram

The geo-fencing app closed an initial seed round of $200,000 from angel investors in 2016. Read more >>

Portfolio NewsBlurr

02JunJune 2, 2017

JDRF Invests in TetraGenetics’ Innovative Approach to Type 1 Diabetes Prevention

A unique scientific approach to preventing, treating and, perhaps one day, curing type 1 diabetes is being coupled with JDRF’s equally innovative approach to funding such studies in a new partnership that might move the promise of a preventive therapy and improved treatment for the condition closer to reality. “This is a very targeted therapeutic approach to addressing type 1 diabetes,” says Dr. Ted Clark, the Chief Scientific Officer for TetraGenetics, a company that has been working for the past several...

Portfolio NewsTetraGenetics